Perirenal Fat Diameter Measured by Echography Could Be an Early Predictor of Lipodystrophy in HIV Type 1--Infected Patients Receiving Highly Active Antiretroviral Therapy

This publication has 20 references indexed in Scilit:

• Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
  AIDS, 2003
• Comparison of Metabolic Abnormalities and Clinical Lipodystrophy 48 Weeks After Switching from HAART to Trizivir™ Versus Continued HAART: The Trizal Study
  HIV Research & Clinical Practice, 2003
• Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy
  AIDS, 2003
• TNF-α promoter region gene polymorphisms in HIV-positive patients with lipodystrophy
  AIDS, 2002
• Lack of Correlation between Length Variation in the DNA Polymerase γ Gene CAG Repeat and Lactic Acidosis or Neuropathy during Antiretroviral Treatment
  AIDS Research and Human Retroviruses, 2002
• Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression
  Clinical Infectious Diseases, 2002
• Impact of Switching from Human Immunodeficiency Virus Type 1 Protease Inhibitors to Efavirenz in Successfully Treated Adults with Lipodystrophy
  Clinical Infectious Diseases, 2000
• Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state
  International Journal of Obesity, 1999
• Ultrasonic measurements of subcutaneous adipose tissue thickness in man
  American Journal of Physical Anthropology, 1986
• Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
  Diabetologia, 1985